Prostatype Genomics CFO Michael af Winklerfelt is leaving the company – recruitment process for the position has begun
Prostatype Genomics CFO Michael af Winklerfelt is leaving the company after three years. Michael will resign from his position as of December 4. The company has started the process of finding a replacement for the function as CFO."We are very grateful for all the work that Michael has carried out during his three years at Prostatype Genomics, in the management team and in close cooperation with the board. In everything from the group's financial management and financial strategy, to efforts in the transformation from a research and development activity to a commercially focused company and